Quince Therapeutics, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| QNCX | ATHE | VYGR | QNTM | ABVC | GANX | |
|---|---|---|---|---|---|---|
| Market cap | 32.27M | 53.35M | 139.87M | 18.13M | 26.16M | 68.52M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | -6.8 | -3.1 | -1.8 | -0.4 | -2.2 | -2.3 |
| Price/book | -0.9 | 1.8 | 0.9 | 2.7 | 2.4 | 6.0 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −91.65% | −38.05% | −54.42% | −82.36% | −67.11% | −23.04% |
| Today | +8.07% | −6.98% | −7.35% | −4.08% | −2.02% | −4.27% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All QNCX news ›Total debt of Quince Therapeutics, Inc. – NASDAQ:IRLA
Quince Therapeutics, Inc. is a biopharmaceutical company, which engages in unlocking the power of a patient’s biology for the treatment of rare diseases. Its product includes eDSP, developed using their proprietary Autologous Intracellular…
Long term debt to total equity ratio of Quince Therapeutics, Inc. – NASDAQ:IRLA
Quince Therapeutics, Inc. is a biopharmaceutical company, which engages in unlocking the power of a patient’s biology for the treatment of rare diseases. Its product includes eDSP, developed using their proprietary Autologous Intracellular…
Asset turnover of Quince Therapeutics, Inc. – NASDAQ:IRLA
Quince Therapeutics, Inc. is a biopharmaceutical company, which engages in unlocking the power of a patient’s biology for the treatment of rare diseases. Its product includes eDSP, developed using their proprietary Autologous Intracellular…
Enterprise value of Quince Therapeutics, Inc. – NASDAQ:IRLA
Quince Therapeutics, Inc. is a biopharmaceutical company, which engages in unlocking the power of a patient’s biology for the treatment of rare diseases. Its product includes eDSP, developed using their proprietary Autologous Intracellular…
Taxes of Quince Therapeutics, Inc. – NASDAQ:IRLA
Quince Therapeutics, Inc. is a biopharmaceutical company, which engages in unlocking the power of a patient’s biology for the treatment of rare diseases. Its product includes eDSP, developed using their proprietary Autologous Intracellular…
Working capital per share of Quince Therapeutics, Inc. – NASDAQ:IRLA
Quince Therapeutics, Inc. is a biopharmaceutical company, which engages in unlocking the power of a patient’s biology for the treatment of rare diseases. Its product includes eDSP, developed using their proprietary Autologous Intracellular…
Non-controlling/minority interest of Quince Therapeutics, Inc. – NASDAQ:IRLA
Quince Therapeutics, Inc. is a biopharmaceutical company, which engages in unlocking the power of a patient’s biology for the treatment of rare diseases. Its product includes eDSP, developed using their proprietary Autologous Intracellular…
Quince Therapeutics - Changes Name To Irulya Therapeutics
TradingView Quince Therapeutics - Changes Name To Irulya Therapeutics
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Most coverage from
-
tradingview.com12
-
defenseworld.net1
-
globenewswire.com1
-
seekingalpha.com1
-
stocktitan.net1
Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 16 articles, not a forecast.